雅虎香港 搜尋

搜尋結果

1. www.medicalnewstoday.com › articles › signs-that-pancreaticPancreatic cancer: Some signs that cancer has spread - ...

   www.medicalnewstoday.com › articles › signs-that-pancreatic

   • 網頁紀錄

   5 天前 · Pancreatic cancer does not usually cause any symptoms until its later stages, when it has spread to other parts of the body. As the cancer progresses, people may develop jaundice, weight loss ...

2. ascopost.com › topics › solid-tumorsPancreatic Cancer - The ASCO Post

   ascopost.com › topics › solid-tumors

   • 網頁紀錄

   2 天前 · Pancreatic cancer is a rare disease, accounting for about 3% of all cancers in the United States. It is the deadliest of all solid malignancies, accounting for about 7% of all cancer deaths each year, and carries a 5-year survival rate of just 11.5%.

3. radiopaedia.org › articles › pancreatic-ductal-adenocarcinomaPancreatic ductal adenocarcinoma | Radiology Reference ...

   radiopaedia.org › articles › pancreatic-ductal-adenocarcinoma

   • 網頁紀錄

   4 天前 · Pancreatic ductal adenocarcinoma, frequently referred to as pancreatic cancer, makes up the vast majority (~90%) of all pancreatic neoplasms and remains a disease with a very poor prognosis and high morbidity. Epidemiology. Pancreatic cancer accounts for 22% of all deaths due to gastrointestinal malignancy, and 5% of all cancer deaths 1.

4. 其他人也問了

   How common is pancreatic cancer?

   • Pancreatic cancer accounts for 22% of all deaths due to gastrointestinal malignancy, and 5% of all cancer deaths 1. In general, it is a malignancy of the elderly with over 80% of cases occurring after the age of 60 1. There is only a weak association, if at all, with heavy alcohol consumption alone, though chronic pancreatitis is a risk factor 1.

   Pancreatic ductal adenocarcinoma | Radiology Reference ... - Radiopaedia

   radiopaedia.org/articles/pancreatic-ductal-adenocarcinoma-4?lang=gb

   查看此問題的所有搜尋結果

   Is pancreatic cancer a rare disease?

   • Pancreatic cancer is a rare disease, accounting for about 3% of all cancers in the United States. It is the deadliest of all solid malignancies, accounting for about 7% of all cancer deaths each year, and carries a 5-year survival rate of just 11.5%. According to the American Cancer Society, in...

   Pancreatic Cancer - The ASCO Post

   ascopost.com/topics/solid-tumors/pancreatic-cancer/

   查看此問題的所有搜尋結果

   What is pancreatic ductal adenocarcinoma?

   • Pancreatic ductal adenocarcinoma, frequently referred to as pancreatic cancer, makes up the vast majority (~90%) of all pancreatic neoplasms and remains a disease with a very poor prognosis and high morbidity. Pancreatic cancer accounts for 22% of all deaths due to gastrointestinal malignancy, and 5% of all cancer deaths 1.

   Pancreatic ductal adenocarcinoma | Radiology Reference ... - Radiopaedia

   radiopaedia.org/articles/pancreatic-ductal-adenocarcinoma-4?lang=gb

   查看此問題的所有搜尋結果

   Are pancreatic head tumours resectable?

   • Most tumours are not resectable at diagnosis. Surgery for stage I and II (see staging of pancreatic cancer) does offer the chance of cure, though with high morbidity (20-30%) and mortality (5%) 3. Resection of pancreatic head tumours is performed with a Whipple operation.

   Pancreatic ductal adenocarcinoma | Radiology Reference ... - Radiopaedia

   radiopaedia.org/articles/pancreatic-ductal-adenocarcinoma-4?lang=gb

   查看此問題的所有搜尋結果

5. ascopubs.org › doi › 10Safety and Efficacy of CT041 in Patients With Refractory ...

   ascopubs.org › doi › 10

   3 天前 · PURPOSE CT041 is a chimeric antigen receptor (CAR)–modified T-cell therapy that specifically targets claudin18.2 in solid tumors. Here, we report the pooled analysis results of two exploratory clinical trials to evaluate CT041 in patients with previously treated pancreatic cancer (PC). PATIENTS AND METHODS These two multicenter, open-label phase I/Ib trials (CT041-CG4006, CT041-ST-01) have a ...

6. www.nature.com › articles › s41420/024/02023-1The bacterial metabolite, lithocholic acid, has ...

   www.nature.com › articles › s41420/024/02023-1

   4 天前 · Pancreatic adenocarcinoma is the seventh leading cause of cancer deaths worldwide, with 496,000 new cases and 466,000 deaths in 2020 [ 1 ]. Patients are typically diagnosed at an advanced stage...

7. aacrjournals.org › cancerres › articleFBXO32 Stimulates Protein Synthesis to Drive Pancreatic ...

   aacrjournals.org › cancerres › article

   • 網頁紀錄

   5 天前 · Abstract. Pancreatic ductal adenocarcinoma (PDAC) is one of the leading causes of cancer-related death worldwide, primarily due to its rapid progression. The current treatment options for PDAC are limited, and a better understanding of the underlying mechanisms responsible for PDAC progression is required to identify improved therapeutic strategies. Here, we identified FBXO32 as an oncogenic ...

8. pubs.acs.org › doi › 10Dual Starvations Induce Pyroptosis for Orthotopic Pancreatic ...

   pubs.acs.org › doi › 10

   5 天前 · Pancreatic cancer is a highly fatal disease, and existing treatment methods are ineffective, so it is urgent to develop new effective treatment strategies. The high dependence of pancreatic cancer cells on glucose and glutamine suggests that disrupting this